Breakthrough invasive fungal infections (bIFI) cause significant morbidity and mortality. Their diagnosis can be challenging due to reduced sensitivity to conventional culture techniques. serologic tests. and PCR-based assays in patients undergoing antifungal therapy. https://foldlyers.shop/product-category/microscopes/